Nplate (Amgen Inc)
Welcome to the PulseAid listing for the Nplate drug offered from Amgen Inc. This Increased Megakaryocyte Maturation [PE],Increased Platelet Production [PE],Thrombopoietin Receptor Agonist [EPC],Thrombopoietin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amgen Inc |
| NON-PROPRIETARY NAME: | romiplostim |
| SUBSTANCE NAME: | ROMIPLOSTIM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Megakaryocyte Maturation [PE],Increased Platelet Production [PE],Thrombopoietin Receptor Agonist [EPC],Thrombopoietin Receptor Agonists [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2008-08-25 |
| END MARKETING DATE: | 0000-00-00 |
Nplate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nplate from Amgen Inc |
| LABELER NAME: | Amgen Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(ug/.5mL) |
| START MARKETING DATE: | 2008-08-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55513-221_af3cf0ec-5402-4893-8ab3-811973c94e47 |
| PRODUCT NDC: | 55513-221 |
| APPLICATION NUMBER: | BLA125268 |
Other ROMIPLOSTIM Pharmaceutical Manufacturers / Labelers:
